U.S. markets open in 5 hours 14 minutes
  • S&P Futures

    3,838.75
    +10.75 (+0.28%)
     
  • Dow Futures

    31,373.00
    +2.00 (+0.01%)
     
  • Nasdaq Futures

    12,872.50
    +40.75 (+0.32%)
     
  • Russell 2000 Futures

    2,197.10
    -2.90 (-0.13%)
     
  • Crude Oil

    62.93
    -0.60 (-0.94%)
     
  • Gold

    1,767.20
    -8.20 (-0.46%)
     
  • Silver

    27.08
    -0.60 (-2.19%)
     
  • EUR/USD

    1.2148
    -0.0038 (-0.32%)
     
  • 10-Yr Bond

    1.5180
    0.0000 (0.00%)
     
  • Vix

    27.78
    +6.44 (+30.18%)
     
  • GBP/USD

    1.3933
    -0.0080 (-0.57%)
     
  • USD/JPY

    106.1740
    -0.0560 (-0.05%)
     
  • BTC-USD

    46,394.52
    -4,007.27 (-7.95%)
     
  • CMC Crypto 200

    926.04
    -7.10 (-0.76%)
     
  • FTSE 100

    6,637.40
    -14.56 (-0.22%)
     
  • Nikkei 225

    28,966.01
    -1,202.26 (-3.99%)
     

Moderna will not enforce COVID-19 vaccine patents during pandemic

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Oct 8 (Reuters) - Moderna Inc said on Thursday it would not enforce patents related to its experimental COVID-19 vaccine while the pandemic continues, a move that would allow other drugmakers to develop shots using the company's technology.

Moderna is not asserting its intellectual property rights for its vaccine technology and is willing to license the technology behind its experimental coronavirus vaccine after the pandemic, the company said in a statement.

The company is one of the furthest along in the U.S. race for a vaccine seen as essential to ending a pandemic that has claimed more than a million lives worldwide.

Moderna has received over $1 billion in government funding to develop and produce its candidate, and another $1.5 billion to supply it to the American public. (Reporting By Mrinalika Roy in Bengaluru; Editing by Aditya Soni)